Elite services to propel complex metabolic disorder trials
![](https://elixiahealth.com/wp-content/uploads/2024/07/complex-metabolic-HEADER-min-uai-258x195.jpg)
EXTENSIVE EXPERTISE IN METABOLIC STUDIES AND PATIENT ACCESS
![null](https://elixiahealth.com/wp-content/uploads/2023/05/Consistent-Global-Enrollment-Leader.png)
#1 leader
In global enrollment for three pharmaceutical companies
![null](https://elixiahealth.com/wp-content/uploads/2023/05/1000-Enrolled-Patients.png)
3,000
Specialty patient populations to drive enrollment in diabetic and obesity trials
![null](https://elixiahealth.com/wp-content/uploads/2023/05/200-Studies.png)
100+
Studies conducted in metabolic disorders
Trust Elixia for access to specialty patient populations with renal and hepatic impairment.
We have delivered rapid enrollment for diabetes and obesity trials in specialty patient populations.
Elixia has conducted more than 100 studies in metabolic disorders, spanning MASH, MAFLD, diabetes, and obesity, in predominantly minority patients. We also have deep experience with varying liver biopsy sample preparation types including flash-frozen.
![](https://elixiahealth.com/wp-content/uploads/2024/07/Trust-Elixia-metabolic-min-uai-258x189.jpg)
WE ARE PROUD TO HAVE PARTNERED WITH
![](https://elixiahealth.com/wp-content/uploads/2024/07/logos_89bio.png)
![](https://elixiahealth.com/wp-content/uploads/2024/07/logos_Altimmune.png)
![](https://elixiahealth.com/wp-content/uploads/2023/04/9B9BAFAE-2D9A-4874-B232-3B150E0C3749-uai-258x62.webp)
![](https://elixiahealth.com/wp-content/uploads/2024/07/logos_Biomea.png)
![](https://elixiahealth.com/wp-content/uploads/2024/07/logos_Boehringer-Engelheim.png)
![](https://elixiahealth.com/wp-content/uploads/2023/04/1F6E86C4-843A-4F8C-8090-A22D528D0D1E-uai-258x88.webp)
![](https://elixiahealth.com/wp-content/uploads/2024/07/logos_Hanmi.png)
![](https://elixiahealth.com/wp-content/uploads/2023/04/Eli-Lilly-uai-258x141.webp)
![](https://elixiahealth.com/wp-content/uploads/2024/07/logos_Madrigal.png)
![](https://elixiahealth.com/wp-content/uploads/2024/07/logos_NeuroBo.png)
![](https://elixiahealth.com/wp-content/uploads/2024/07/logos_NovoNordisk.png)
![](https://elixiahealth.com/wp-content/uploads/2024/07/logos_Rivus.png)
![](https://elixiahealth.com/wp-content/uploads/2024/07/logos_Shionogi.png)
![](https://elixiahealth.com/wp-content/uploads/2024/07/logos_Viking.png)
Our research areas
Elixia’s research sites and physician investigators have successfully completed studies in many therapeutic subcategories in the infectious disease space.
![null](https://elixiahealth.com/wp-content/uploads/2023/06/Hepatic.png)
MASH/NASH
![null](https://elixiahealth.com/wp-content/uploads/2024/07/Obesity.png)
Obesity
![null](https://elixiahealth.com/wp-content/uploads/2023/06/Hepatic.png)
MAFLD/MASLD
![null](https://elixiahealth.com/wp-content/uploads/2023/05/Type-2-Diabetes.png)